FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012683575> ?p ?o ?g. }

• W2012683575 endingPage "462" @default.
• W2012683575 startingPage "455" @default.
• W2012683575 abstract "Immunohistochemical expression of p53, Bc12, vimentin, and S100 protein-positive Langerhans cell was evaluated in 50 endometrial carcinomas (6 stage I, 14 stage II, 20 stage III, and 10 stage IV), in an attempt to use these markers as predictors of survival. Monoclonal antibodies to p53, Bcl-2, vimentin, and S100 proteins were applied to paraffin-embedded sections of endometrial adenocarcinoma, using the avidin-biotin peroxidase complex technique (ABC). All 20 patients with stage I and II carcinomas were alive with a mean follow-up of 3 years. Of 30 patients with stage III and IV carcinomas, 13 died of tumor (3-year survival, 57%; SE, 10%), eight were alive with tumor, and nine were alive with no evidence of tumor (mean follow-up, 46 months). Strong p53 positivity was present in 11 carcinomas (22%), including nine high-stage and two low-stage tumors. Bcl-2 positivity was identified in 33 tumors (66%). These tumors were mostly low stage; however, no correlation was found between Bcl-2 expression and prognosis. Vimentin positivity (P < .001), and tumor infiltration by a large number of S100 protein-positive Langerhans cells (P < .05) were associated with low-stage tumors. Vimentin was expressed in 23 carcinomas, including 70% of low-stage tumors and 20% of high-stage tumors. Most high-grade carcinomas were Langerhans cell depleted; most low-grade carcinomas showed >50 S100 protein-positive Langerhans cells/10 high-power fields. Our results indicate that Langerhans cell infiltration and vimentin positivity of tumor cells are favorable prognostic factors in endometrial carcinomas." @default.
• W2012683575 created "2016-06-24" @default.
• W2012683575 creator A5023244550 @default.
• W2012683575 creator A5026126784 @default.
• W2012683575 creator A5029831406 @default.
• W2012683575 creator A5062533584 @default.
• W2012683575 creator A5076324164 @default.
• W2012683575 date "1998-05-01" @default.
• W2012683575 modified "2023-10-01" @default.
• W2012683575 title "Prognostic significance of p53, bcl-2, vimentin, and S 100 protein-positive langerhans cells in endometrial carcinoma" @default.
• W2012683575 cites W121222821 @default.
• W2012683575 cites W1555474118 @default.
• W2012683575 cites W1562900393 @default.
• W2012683575 cites W1571487648 @default.
• W2012683575 cites W1604883536 @default.
• W2012683575 cites W1847864430 @default.
• W2012683575 cites W1890985457 @default.
• W2012683575 cites W1972311492 @default.
• W2012683575 cites W1979319210 @default.
• W2012683575 cites W1981155714 @default.
• W2012683575 cites W1981823615 @default.
• W2012683575 cites W1985888795 @default.
• W2012683575 cites W1995856480 @default.
• W2012683575 cites W2002964194 @default.
• W2012683575 cites W2005210563 @default.
• W2012683575 cites W2009603041 @default.
• W2012683575 cites W2009867490 @default.
• W2012683575 cites W2010066662 @default.
• W2012683575 cites W2015519364 @default.
• W2012683575 cites W2023491780 @default.
• W2012683575 cites W2060937867 @default.
• W2012683575 cites W2068691401 @default.
• W2012683575 cites W2078058864 @default.
• W2012683575 cites W2078457332 @default.
• W2012683575 cites W2078962174 @default.
• W2012683575 cites W2079526847 @default.
• W2012683575 cites W2081894694 @default.
• W2012683575 cites W2083526422 @default.
• W2012683575 cites W2084147994 @default.
• W2012683575 cites W2088189897 @default.
• W2012683575 cites W2090429900 @default.
• W2012683575 cites W2090970424 @default.
• W2012683575 cites W2091398214 @default.
• W2012683575 cites W2092551238 @default.
• W2012683575 cites W2103870277 @default.
• W2012683575 cites W2144695914 @default.
• W2012683575 cites W2146642286 @default.
• W2012683575 cites W2159329636 @default.
• W2012683575 cites W2261888961 @default.
• W2012683575 cites W2320319314 @default.
• W2012683575 cites W2330609930 @default.
• W2012683575 cites W2401196811 @default.
• W2012683575 cites W2439883951 @default.
• W2012683575 cites W5304649 @default.
• W2012683575 cites W65092068 @default.
• W2012683575 doi "https://doi.org/10.1016/s0046-8177(98)90060-0" @default.
• W2012683575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9596268" @default.
• W2012683575 hasPublicationYear "1998" @default.
• W2012683575 type Work @default.
• W2012683575 sameAs 2012683575 @default.
• W2012683575 citedByCount "52" @default.
• W2012683575 countsByYear W20126835752012 @default.
• W2012683575 countsByYear W20126835752013 @default.
• W2012683575 countsByYear W20126835752014 @default.
• W2012683575 countsByYear W20126835752016 @default.
• W2012683575 countsByYear W20126835752017 @default.
• W2012683575 countsByYear W20126835752018 @default.
• W2012683575 countsByYear W20126835752019 @default.
• W2012683575 countsByYear W20126835752020 @default.
• W2012683575 countsByYear W20126835752021 @default.
• W2012683575 countsByYear W20126835752022 @default.
• W2012683575 countsByYear W20126835752023 @default.
• W2012683575 crossrefType "journal-article" @default.
• W2012683575 hasAuthorship W2012683575A5023244550 @default.
• W2012683575 hasAuthorship W2012683575A5026126784 @default.
• W2012683575 hasAuthorship W2012683575A5029831406 @default.
• W2012683575 hasAuthorship W2012683575A5062533584 @default.
• W2012683575 hasAuthorship W2012683575A5076324164 @default.
• W2012683575 hasConcept C121608353 @default.
• W2012683575 hasConcept C126322002 @default.
• W2012683575 hasConcept C142724271 @default.
• W2012683575 hasConcept C146357865 @default.
• W2012683575 hasConcept C147447768 @default.
• W2012683575 hasConcept C151730666 @default.
• W2012683575 hasConcept C204232928 @default.
• W2012683575 hasConcept C2777546739 @default.
• W2012683575 hasConcept C2779012181 @default.
• W2012683575 hasConcept C2780851604 @default.
• W2012683575 hasConcept C2781182431 @default.
• W2012683575 hasConcept C502942594 @default.
• W2012683575 hasConcept C71924100 @default.
• W2012683575 hasConcept C86803240 @default.
• W2012683575 hasConceptScore W2012683575C121608353 @default.
• W2012683575 hasConceptScore W2012683575C126322002 @default.
• W2012683575 hasConceptScore W2012683575C142724271 @default.
• W2012683575 hasConceptScore W2012683575C146357865 @default.
• W2012683575 hasConceptScore W2012683575C147447768 @default.
• W2012683575 hasConceptScore W2012683575C151730666 @default.

• next